Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin for GVHD Prophylaxis in Pediatric ALL Post-Transplant
NCT00795886Phase 2Completed
- Sponsor
- University of Utah
- Start
- Aug 2005
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in acute lymphoblastic leukemia (ALL), graft-versus-host disease (GVHD), sponsored by University of Utah. Started Aug 2005; status: completed.
02
Drugs
sirolimus
03
Conditions
acute lymphoblastic leukemia (ALL)graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00795886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00795886.